RLYB · Rallybio Corp

$17.01 +0.02 (+0.12%)

Market Cap

$90.23M

5.31M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Stephen Uden	Chief Executive Officer and President	$551,200	—	—	$314,626	$248,040	$13,800	$1,127,666
Martin W. Mackay	Chairman, former Executive Chairman	$551,200	—	—	$314,626	$223,236	$13,800	$1,102,862
Steven Ryder	Chief Medical Officer	$531,227	—	—	$174,792	$191,242	$13,800	$911,061
Jonathan I. Lieber	M.B.A. Chief Financial Officer and Treasurer	$478,400	—	—	$174,792	$172,224	$13,800	$839,216

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Jonathan I. Lieber	M.B.A. Chief Financial Officer and Treasurer	$422,667	$100,000	—	$1,245,096	$118,067	$13,200	$1,899,030
Martin W. Mackay	Chairman, former Executive Chairman	$530,000	—	—	$1,054,934	$166,950	$13,200	$1,765,084
Stephen Uden	Chief Executive Officer and President	$530,000	—	—	$1,054,934	$166,950	$13,200	$1,765,084
Steven Ryder	Chief Medical Officer	$510,796	—	—	$586,622	$143,023	$13,200	$1,253,641

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Stephen Uden	Chief Executive Officer and President	$491,150	—	—	$691,108	$198,916	$17,000	$1,398,174
Jeffrey M. Fryer	Former Chief Financial Officer and Treasurer	$491,150	—	—	$691,108	$198,916	$17,000	$1,398,174
Martin W. Mackay	Executive Chairman and former Chief Executive Officer	$491,150	—	—	$691,108	$198,916	$17,000	$1,398,174

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Jeffrey M. Fryer	Former Chief Financial Officer and Treasurer	$441,212	—	$753,847	$1,515,200	$167,661	$16,500	$2,894,420
Stephen Uden	President, Chief Operating Officer and Chief Scientific Officer	$441,212	—	$753,847	$1,515,200	$167,661	$16,500	$2,894,420
Martin W. Mackay	Chief Executive Officer and Chairman	$441,212	—	$753,847	$1,515,200	$167,661	$16,500	$2,894,420

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Jeffrey M. Fryer	Chief Financial Officer and Treasurer	$379,500	—	$292,600	—	$151,800	$14,156	$838,056
Martin W. Mackay	Chief Executive Officer and Chairman	$379,500	—	$292,600	—	$151,800	$14,156	$838,056
Stephen Uden	President, Chief Operating Officer and Chief Scientific Officer	$379,500	—	$292,600	—	$151,800	$14,156	$838,056

Executive changes

Person	Role	Change	Effective	Filed
Steven Ryder	Chief Medical Officer	Terminated	2026-03-31	2026-03-31
Dr. Kush Parmar	member of the Board and as Chair of the Nominating and Corporate Governance Committee of the Board	Resigned	2024-10-31	2024-09-17
Martin Mackay	Executive Chairman	Resigned	2024-12-31	2024-07-23
Martin Mackay, Ph.D.	Executive Chairman	Appointed	2023-08-01	2023-06-29
Stephen Uden, M.D.	director	Appointed	2023-08-01	2023-06-29
Stephen Uden, M.D.	Chief Executive Officer	Appointed	2023-08-01	2023-06-29
Jonathan I. Lieber	Chief Financial Officer and Treasurer	Appointed	2023-02-01	2023-01-31
Wendy K. Chung, M.D., Ph.D.	director	Appointed	2022-08-01	2022-08-02
Hui Liu, Ph.D.	director	Appointed	2022-04-04	2022-04-04
Christine A. Nash	director	Appointed	2022-04-04	2022-04-04

Key facts CIK 1739410 CUSIP 75120L209 13F (30d) 42 filings 40 filers Visit website Investor relations